المؤلفون: Ansell S. M., Brockelmann P. J., von Keudell G., Lee H. J., Santoro A., Zinzani P. L., Collins G. P., Cohen J. B., de Boer J. P., Kuruvilla J., Savage K. J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M. A., Engert A., Armand P.

المساهمون: Ansell S.M., Brockelmann P.J., von Keudell G., Lee H.J., Santoro A., Zinzani P.L., Collins G.P., Cohen J.B., de Boer J.P., Kuruvilla J., Savage K.J., Trneny M., Provencio M., Jager U., Willenbacher W., Wen R., Akyol A., Mikita-Geoffroy J., Shipp M.A., Engert A., Armand P.

مصطلحات موضوعية: Nivolumab, relapsed/refractory, Hodgkin lymphoma, 5-year survival, CheckMate 205 study

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37530622; info:eu-repo/semantics/altIdentifier/wos/WOS:001097076600001; volume:7; issue:20; firstpage:6266; lastpage:6274; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/960011Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85175416545; https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classicalTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2023010334Test
https://hdl.handle.net/11585/960011Test
https://ashpublications.org/bloodadvances/article/7/20/6266/497222/Nivolumab-for-relapsed-refractory-classicalTest

المؤلفون: Tam, C. S., Kapoor, P., Castillo, J. J., Buske, C., Ansell, S. M., Branagan, A. R., Kimby, E., Li, Y., Palomba, M. L., Qiu, L., Shadman, M., Abeykoon, J. P., Sarosiek, S., Vos, J., Yi, S., Stephens, D., Roos-Weil, D., Roccaro, A. M., Morel, Pierre, Munshi, N. C., Anderson, K. C., San-Miguel, J., Garcia-Sanz, R., Dimopoulos, M. A., Treon, S. P., Kersten, M. J.

المساهمون: Université de Lille, CHU Lille, Monash University Melbourne, Mayo Clinic Rochester, Dana-Farber Cancer Institute Boston, Universitätsklinikum Ulm - University Hospital of Ulm, Massachusetts General Hospital Boston, Karolinska Institutet Stockholm, Baylor College of Medicine BCM, Memorial Sloan Kettering Cancer Center MSKCC, China Academy of Chinese Medical Sciences, University of Washington Seattle, University of Amsterdam Amsterdam = Universiteit van Amsterdam UvA, Tianjin University TJU, University of Utah, CHU Pitié-Salpêtrière AP-HP, Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia Brescia, Université de Picardie Jules Verne UPJV, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Clínica Universidad de Navarra Pamplona, Universidad de Salamanca, National and Kapodistrian University of Athens NKUA

مصطلحات موضوعية: IgM lymphoplasmacytic lymphoma, Waldenstrom macroglobulienmia, BTK Inhibitor, Chemoimmunotherapy, Clinical trials

وصف الملف: application/octet-stream

العلاقة: Semin Hematol; http://hdl.handle.net/20.500.12210/89807Test

الإتاحة: https://doi.org/20.500.12210/89807Test
https://hdl.handle.net/20.500.12210/89807Test

المؤلفون: Zinzani, P. L., Ansell, S. M., Bosch, F., Friedberg, J. W., Marolleau, J. P., Arcaini, L., Garcia-Sanz, R., Gopal, A. K., Grande, C., Merryman, R., Pinto, A., Smith, S. D., Villasboas, J. C., Wallace, D., Fagerberg, J., Magalhaes, J. G., Armand, P.

المصدر: HemaSphere ; volume 6, page 1005-1006 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000847328.48663.29Test

المؤلفون: Hutchings, M., Ansell, S. M., Straus, D. J., Connors, J. M., Kim, W. S., Gallamini, A., Ramchandren, R., Friedberg, J. W., Advani, R., Evens, A. M., Smolewski, P., Savage, K. J., Bartlett, N. L., Eom, H.-S., Abramson, J. S., Dong, C., Campana, F., Fenton, K., Puhlmann, M., Radford, J.

المصدر: HemaSphere ; volume 6, page 101-102 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000843692.94815.d7Test

المؤلفون: Straus D. J., Dlugosz-Danecka M., Alekseev S., Illes A., Picardi M., Lech-Maranda E., Feldman T., Smolewski P., Savage K. J., Bartlett N. L., Walewski J., Ramchandren R., Zinzani P. L., Hutchings M., Connors J. M., Radford J., Munoz J., Kim W. S., Advani R., Ansell S. M., Younes A., Miao H., Liu R., Fenton K., Forero-Torres A., Gallamini A.

المساهمون: Straus, D. J., Dlugosz-Danecka, M., Alekseev, S., Illes, A., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Ramchandren, R., Zinzani, P. L., Hutchings, M., Connors, J. M., Radford, J., Munoz, J., Kim, W. S., Advani, R., Ansell, S. M., Younes, A., Miao, H., Liu, R., Fenton, K., Forero-Torres, A., Gallamini, A.

مصطلحات موضوعية: Clinical Trials and Observation, Lymphoid Neoplasia, Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Bleomycin, Brentuximab Vedotin, Dacarbazine, Doxorubicin, Female, Follow-Up Studie, Hodgkin Disease, Human, Intention to Treat Analysi, Male, Middle Aged, Neoplasm Staging, Survival Analysi, Treatment Outcome, Vinblastine

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000523314100008; volume:135; issue:10; firstpage:735; lastpage:742; numberofpages:8; journal:BLOOD; http://hdl.handle.net/11588/823875Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85081944235

الإتاحة: https://doi.org/10.1182/BLOOD.2019003127Test
http://hdl.handle.net/11588/823875Test

المؤلفون: Tun, A. M, Wang, Y, Maliske, S, Farooq, U, Micallef, I. N, Inwards, D. J, Porrata, L. F, Ansell, S. M, Rosenthal, A. C, Kharfan‐Dabaja, M, Link, B. K, Villasboas, J. C, Paludo, J, Cerhan, J. R, Habermann, T. M, Witzig, T. E, Nowakowski, G. S, Johnston, P. B

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.98_2880Test

المؤلفون: Desai, S. H., Mwangi, R., Maurer, M., King, R., Cerhan, J., Feldman, A., Habermann, T., Farooq, U., Thompson, C., Wang, Y., Ansell, S. M., Witzig, T. E., Nowakowski, G. N.

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.66_2879Test

المؤلفون: Tun, A. M, Maliske, S, Wang, Y, Maurer, M. J, Micallef, I. N, Inwards, D. J, Porrata, L. F, Rosenthal, A. C, Kharfan‐Dabaja, M, Orme, J, Link, B. K, Cerhan, J. R, Thompson, C. A, Habermann, T. M, Witzig, T. E, Ansell, S. M, Nowakowski, G. S, Farooq, U, Johnston, P. B

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.97_2880Test

المؤلفون: Zinzani, P. L., Carlo‐Stella, C., Hamadani, M., Herrera, A. F., Ansell, S. M., Radford, J., Maddocks, K., Kline, J., Savage, K. J., Bartlett, N. L., Caimi, P. F., Negievich, Y., Cruz, H. G., Wang, L., Wuerthner, J., Collins, G. P.

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.75_2879Test

المؤلفون: Ansell, S. M., Bröckelmann, P. J., von Keudell, G., Lee, H. J., Santoro, A., Zinzani, P. L., Collins, G. P., Cohen, J. B., De Boer, J. P., Kuruvilla, J., Savage, K. J., Trneny, M., Provencio, M., Jaeger, U., Willenbacher, W., Swanink, R., Sacchi, M., Shipp, M. A., Engert, A., Armand, P.

المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069

الإتاحة: https://doi.org/10.1002/hon.74_2879Test